Cilostazol and Phoslo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cilostazol (cilostazol) and Phoslo (calcium acetate). Common drug interactions include anxiety among females and blood pressure decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Cilostazol and Phoslo. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.



On Jul, 11, 2026

26 people who take Cilostazol and Phoslo together, and have interactions are studied.

Cilostazol and Phoslo drug interactions.

What are the common drug interactions of Cilostazol and Phoslo, by gender? *:

female:

  1. Anxiety
  2. Asthenia (weakness)
  3. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  4. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  5. Pain
  6. Anaemia (lack of blood)
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  9. Emotional distress
  10. Hyperlipidaemia (presence of excess lipids in the blood)

male:

  1. Blood pressure decreased
  2. Brain injury
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Drug effect decreased
  6. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  7. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Dyspnoea (difficult or laboured respiration)
  10. Headache (pain in head)

What are the common drug interactions of Cilostazol and Phoslo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Anxiety
  3. Asthenia (weakness)
  4. Emotional distress
  5. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  6. Joint range of motion decreased (disease of joint movement)
  7. Mobility decreased (ability to move is reduced)
  8. Muscle tightness
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Oedema peripheral (superficial swelling)

60+:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Anaemia (lack of blood)
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Cardioactive drug level increased
  5. Diarrhoea
  6. Hypertension (high blood pressure)
  7. Hypophagia (reduced food intake)
  8. Impaired healing
  9. Unresponsive to stimuli
  10. Abdominal distension

What are the existing conditions these people have? *

  1. Nuclear Magnetic Resonance Imaging Abdominal: 9 people, 34.62%
  2. Nuclear Magnetic Resonance Imaging Brain: 5 people, 19.23%
  3. Kidney Transplant Rejection: 5 people, 19.23%
  4. Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and Phoslo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cilostazol and Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cilostazol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cilostazol and calcium acetate (the active ingredients of Cilostazol and Phoslo, respectively), and Cilostazol and Phoslo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: